课题基金 / 基金详情

Analysis of viral counter regulation against host's defense mechanism for viral infection using HCV transgenic mouse model

Analysis of viral counter regulation against host's defense mechanism for viral infection using HCV transgenic mouse model
利用HCV转基因小鼠模型分析病毒对宿主病毒感染防御机制的反调节
批准号:
09470088
负责人:
WAKITA Takaji
金额:
$6.66万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

WAKITA Takaji的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Missing of proper culture system and animal model has hampered fine analysis of viral life cycle and pathogenesis of HCV infection. We established HCV transgenic mouse model using Cre/loxP switching system. We put neomycin resistance gene as a stuffer flanked by loxP sequence at both 5' and 3' end between CAG promoter and core to NS2, HCV cDNA CN2. Spleens were harvested from CN2 transgenic mice. In 2 lineages out of 8, cultured spleen cell and fibroblast highly expressed core, E1 and E2 proteins by western blot and immunostaining after infection with recombinant adeno virus (AxCANCre) which express cre DNA recombinase in infected cell. To induce HCV expression in vivo and in the liver, we injected AxCANCre to CN2 transgenic mouse from tail vein and HCV protein expression was confirmed in its liver tissue. With the expression of HCV structural protein, acute liver injury which was similar to human acute viral hepatitis was occurred. It was accompanied with apoptotic liver cell death. Serum core protein was detected in transgenic mice 7 days after AxCANCre injection with evident serum ALT elevations, subsequently, anti-core antibody response was detected at 14 days after infection. Furthermore, CD4 and CD8 positive cell depletion assay normalized the serum ALT elevations of mice and pathological changes in the liver. These results suggest that HCV proteins are not direct cytopathic and the host immune response has a pivotal roles in HCV infection. This transgenic mouse model system allows us to analyze the functions of viral products and host immune system in HCV infection and hepatocellular carcinogenesis of HCV.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
脇田隆字: "Cre/loxシステムを利用したHCVトランスジェニックマウスの確立" ウイルス. 48. 9-18 (1998)
Takaji Wakita:“利用 Cre/lox 系统建立 HCV 转基因小鼠”病毒。 48. 9-18 (1998)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Geissler M et al: "Differential cellular and humoral immune responses to HCV core and HBV envelope proteins after genetic immunizations using chimeric constructs." Vaccine. 16. 857-867 (1998)
Geissler M 等人:“使用嵌合结构进行基因免疫后,对 HCV 核心和 HBV 包膜蛋白的细胞和体液免疫反应存在差异。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Wakita T et al: "Antiviral effects of antisense RNA on hepatitis C virus RNA translation and expression." J.Med.Virol.57. 217-222 (1999)
Wakita T 等人:“反义 RNA 对丙型肝炎病毒 RNA 翻译和表达的抗病毒作用。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
T Tanaka et al: "Acute hepatitis caused by sexual or household transmission of GBV-C J." Hepatology. 27. 1110-1112 (1997)
T Tanaka 等人:“GBV-C J 性传播或家庭传播引起的急性肝炎。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
75
    Analysis of hepatitis C virus sequence quasi species by NGS
    • 批准号:
      23659407
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.33万
    • 财政年份:
      2011
    • 负责人:
      WAKITA Takaji
    • 依托单位:
    Cell culture system for genotype1b hepatitis C virus
    • 批准号:
      21390235
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.4万
    • 财政年份:
      2009
    • 负责人:
      WAKITA Takaji
    • 依托单位:
    Analysis of factors involved in viral replication efficiency and search for novel anti -virals using HCV culture systems.
    • 批准号:
      18390225
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.58万
    • 财政年份:
      2006
    • 负责人:
      WAKITA Takaji
    • 依托单位:
    Analysis of replication of Hepatitis C Virus using highly efficient replication system
    海外基金